» Articles » PMID: 38605594

Digital Health in Diabetes and Cardiovascular Disease

Overview
Journal Endocr Res
Publisher Informa Healthcare
Specialty Endocrinology
Date 2024 Apr 12
PMID 38605594
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Digital health technologies are rapidly evolving and transforming the care of diabetes and cardiovascular disease (CVD).

Purpose Of The Review: In this review, we discuss emerging approaches incorporating digital health technologies to improve patient outcomes through a more continuous, accessible, proactive, and patient-centered approach. We discuss various mechanisms of potential benefit ranging from early detection to enhanced physiologic monitoring over time to helping shape important management decisions and engaging patients in their care. Furthermore, we discuss the potential for better individualization of management, which is particularly important in diseases with heterogeneous and complex manifestations, such as diabetes and cardiovascular disease. This narrative review explores ways to leverage digital health technology to better extend the reach of clinicians beyond the physical hospital and clinic spaces to address disparities in the diagnosis, treatment, and prevention of diabetes and cardiovascular disease.

Conclusion: We are at the early stages of the shift to digital medicine, which holds substantial promise not only to improve patient outcomes but also to lower the costs of care. The review concludes by recognizing the challenges and limitations that need to be addressed for optimal implementation and impact. We present recommendations on how to navigate these challenges as well as goals and opportunities in utilizing digital health technology in the management of diabetes and prevention of adverse cardiovascular outcomes.

Citing Articles

Leveraging Mobile Health and Wearable Technologies for the Prevention and Management of Atherosclerotic Cardiovascular Disease.

Alipour P, El-Aghil M, Foo A, Azizi Z Curr Atheroscler Rep. 2025; 27(1):31.

PMID: 39932603 DOI: 10.1007/s11883-024-01272-w.


Bridging the Gap: How Accounting for Social Determinants of Health Can Improve Digital Health Equity in Cardiovascular Medicine.

Kim D, Eltahir A, Ngo S, Rodriguez F Curr Atheroscler Rep. 2024; 27(1):9.

PMID: 39576395 DOI: 10.1007/s11883-024-01249-9.

References
1.
Anderson J . Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes. Diabetes Spectr. 2020; 33(2):165-174. PMC: 7228816. DOI: 10.2337/ds19-0031. View

2.
Mayberry L, Guy C, Hendrickson C, McCoy A, Elasy T . Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings. J Gen Intern Med. 2023; 38(11):2546-2552. PMC: 10228889. DOI: 10.1007/s11606-023-08222-3. View

3.
Al-Halafi A . Applications of artificial intelligence-assisted retinal imaging in systemic diseases: A literature review. Saudi J Ophthalmol. 2023; 37(3):185-192. PMC: 10701145. DOI: 10.4103/sjopt.sjopt_153_23. View

4.
Bhupathiraju S, Hu F . Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications. Circ Res. 2016; 118(11):1723-35. PMC: 4887150. DOI: 10.1161/CIRCRESAHA.115.306825. View

5.
Kamga P, Mostafa R, Zafar S . The Use of Wearable ECG Devices in the Clinical Setting: a Review. Curr Emerg Hosp Med Rep. 2022; 10(3):67-72. PMC: 9244148. DOI: 10.1007/s40138-022-00248-x. View